ANTI-COLLAGEN TRIPLE HELIX REPEAT CONTAINING 1 (CTHRC1) ANTIBODIES AND METHODS OF USING THE SAME

Abstract: collagen triple helix repeat containing 1 (cthrc1) was identified from a subtractive hybridization cdna library, seeking genes associated with repair of arterial injury. the present invention is directed to anti-cthrc1 antibodies, compositions comprising the same, and methods of using such antibodies and compositions for the prevention, diagnosis and treatment of a disease or disorder, such as, e.g., cancer, bone disease, fibrotic disease, arthritis, and osteoporosis.

Inventor(s): Sam Cooper, Allison Nixon, Max London, Elizabeth Koch, Christopher Harvey, Michael Briskin

CPC Classification: A61K47/68031 ({Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates})

Search for rejections for patent application number 20250213710